Cancer Research Institute

10/08/2026

This , consider how your Donor Advised Fund can make a lasting impact on cancer research.

By recommending a grant to the Cancer Research Institute, you can help support innovative research and advance new discoveries in cancer immunotherapy.

Learn more about giving through your DAF: https://bit.ly/47sc6tQ

10/07/2026

As the world celebrates this year's Nobel Prize announcements, we're reflecting on CRI's long history of recognizing groundbreaking science.

12 recipients of CRI's William B. Coley Award have gone on to win the Nobel Prize. Their discoveries have transformed our understanding of the immune system, advanced cancer treatment, and shaped modern medicine.

Explore the scientists and their lasting impact. 👉

Learn more about the William B. Coley Award: https://bit.ly/4zk1Ek9

10/06/2026

This , explore new treatment options, what researchers are studying next, and how CRI-supported science has advanced the field. https://bit.ly/4ymATvr

10/05/2026

Meet Reuven Agami, PhD, a scientist exploring a hidden part of our biology that could hold new ways to fight cancer.

Dr. Agami leads the CRI-supported Cancer Grand Challenges ILLUMINE team, which is searching for new targets that could help the immune system recognize and attack tumors, especially in hard-to-treat cancers.

Reuven Agami on curiosity, serendipity and the dark proteome

10/02/2026

When LaToya was diagnosed with breast cancer, she wasn't offered immunotherapy as an initial treatment option.

After doing her own research, she enrolled in a clinical trial for cutting-edge immunotherapy. Today, she's a survivor, sharing her story in hopes that her children will never face cancer.

Hear LaToya's story: https://bit.ly/4yWTy0N

Know someone who needs to hear this? Share it with them. 💗

LaToya Bolds-Johnson shares her journey from misdiagnosis to participating in an immunotherapy clinical trial, inspiring hope for others facing cancer.

10/01/2026

🏃 is hitting the road this October and November!

Here’s where our runners will be:

Oct. 4: Cardiff Half Marathon
Oct. 25: Irish Life Dublin Marathon
Oct. 25: Valencia Half Marathon
Nov. 1: TCS New York City Marathon

Want to join? Guaranteed entries are still available for select races. Request an entry to run in support of cancer research, or come out and cheer on our runners! https://bit.ly/4rtArcb

09/30/2026

🎗️ This , CRI STAR and pediatric oncologist Robbie Majzner, MD, explains why some immunotherapies work differently in children and how researchers are exploring new ways to help the immune system recognize and attack pediatric cancers.

Read the full story: https://bit.ly/3T2vRot

09/29/2026

Victoria “Vicky” Ann Michelis did not want ovarian cancer to define her. She wanted to be remembered for how she lived and how deeply she cared for others.

After facing a rare and aggressive form of ovarian cancer, Vicky became passionate about raising awareness and helping others facing the disease.

Today, one of her best friends, Rob Malone, is carrying that generosity forward through the Victoria Ann Michelis Fund. The fund supports small U.S.-based nonprofits across causes Vicky cared about, including CRI research to bring more treatment options, like immunotherapy, to people with ovarian and other cancers.

Read Vicky’s story and how her legacy continues: https://bit.ly/47dZN4c

09/28/2026

Could a single blood draw show whether immunotherapy is working?

A study at Johns Hopkins Kimmel Cancer Center, led by CRI-funded scientist Valsamo Anagnostou, MD, PhD, found that a single blood draw just weeks after starting immunotherapy may reveal whether treatment is working in patients with advanced lung cancer, before scans provide clear answers.

Learn more about Dr. Anagnostou and her CRI-funded research: https://bit.ly/47bUcLH

Blood Test Predicts Immunotherapy Benefit Early 08/03/2026 Prospective Johns Hopkins biobanking program validates practical liquid biopsy approach that could guide early treatment decisions The Johns Hopkins Kimmel Cancer Center Thoracic Clinical Research Program Team Credit: Vincent Lam Fast Facts....

09/26/2026

⛳ Thank you to everyone who joined us for the second annual Daniel James McMahon Memorial Fund Golf Outing last week in Rockford, Illinois.

Nearly 150 golfers came together to celebrate the life of Dan McMahon, a beloved musician and connector who passed away from esophageal cancer at just 41 years old.

We’re grateful to everyone who helped honor Dan’s legacy while supporting cancer research and helping make new discoveries possible.

Thank you for being part of such a meaningful day. 🧡